Pierre-Jean Le Reste
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pierre-Jean Le Reste has a total of 227 co-authors. Here are the top co-authors by number of shared publications:
- Eric Chevet
Inserm U1242, Université de Rennes, Centre de lutte contre le cancer Eugène Marquis, Rennes, France
9 shared publications - Tony Avril
Université de Rennes 1 INSERM U1242 , 35000 Rennes
8 shared publications Xavier Morandi
Department of Neurosurgery, Rennes University Hospital, Rennes, France; University of Rennes, University Hospital of Rennes, French National Institute of Health and Medical Research, Rennes, France
8 shared publications- Véronique Quillien
Centre Eugene Marquis
7 shared publications Evelyne Emery
Departement of Neurosurgery, University Hospital of Caen, University of Lower Normandy, Caen, France
5 shared publicationsJacques Guyotat
Service of Neurosurgery D, Lyon Civil Hospitals, Pierre Wertheimer Neurological and Neurosurgical Hospital, Lyon, France
5 shared publications
Latest Publications
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Mise au point d'un modèle préclinique pertinent pour étudier le ciblage thérapeutique des voies du stress du réticulum endoplasmique dans le glioblastome
Le glioblastome (GBM) est la plus fréquente des tumeurs cérébrales malignes. Son pronostic reste très mauvais malgré des thérapeutiques multimodales, la médiane de survie étant d’environ 15 mois. Le reticulum endoplasmique (RE) est un organite intracellulaire aux rôles multiples, notamment la production et le repliement des protéines. Dans certaines conditions de stress cellulaire, le RE peut être soumis à une accumulation de protéines mal repliées et déclencher l’Unfolded Protein Response (UPR). L’UPR est un processus adaptatif permettant soit de rétablir l’homéostasie protéique, soit de déclencher une apoptose. Dans cette thèse, nous proposons d’étudier le rôle de l’UPR dans l’agressivité du glioblastome, et d’essayer de déterminer dans quelle mesure son ciblage par des agents pharmacologiques innovants a un impact sur le pronostic oncologique. Pour cela, nous avons commencé par démontrer que IRE1, une protéine senseur de l’UPR, a um impact sur l’agressivité tumorale, notamment par son activité d’épissage de l’ARNm codant pour XBP1. La signalisation induite par xpb1 entraine une infiltration macrophagique, une néo- angiogénèse et um profil invadif des GBM. Ensuite, nous proposons de definir une drogue ciblant l’axe IRE1/xpb1, la drogue candidate retenue étant le MKC8866, un inhibiteur sélectif de l’activité RNase d’IRE1. Enfin, nous proposons d’évaluer l’impact de cet inhibiteur sur le développement tumoral, par le biais d’un ciblage intracérébral, couplé à une exérese et une radio-chimiothérapie, dans un modele syngénique murin innovant. Ce ciblage nous a permis de mettre en évidence un bénéfice oncologique à cibler IRE1 en plus des thérapeutiques conventionnelles. Ce travail constitue une preuve de concept préclinique de l’efficacité du ciblage de l’UPR, et propose um modele préclinique de l’efficacité du ciblage de l’UPR, et propose um modele préclinique innovant pouvant servir à l’étude d’autres voies de signalisation d’intérêt.
- 8 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Mise au point d'un modèle préclinique pertinent pour étudier le ciblage thérapeutique des voies du stress du réticulum endoplasmique dans le glioblastome
Le glioblastome (GBM) est la plus fréquente des tumeurs cérébrales malignes. Son pronostic reste très mauvais malgré des thérapeutiques multimodales, la médiane de survie étant d’environ 15 mois. Le reticulum endoplasmique (RE) est un organite intracellulaire aux rôles multiples, notamment la production et le repliement des protéines. Dans certaines conditions de stress cellulaire, le RE peut être soumis à une accumulation de protéines mal repliées et déclencher l’Unfolded Protein Response (UPR). L’UPR est un processus adaptatif permettant soit de rétablir l’homéostasie protéique, soit de déclencher une apoptose. Dans cette thèse, nous proposons d’étudier le rôle de l’UPR dans l’agressivité du glioblastome, et d’essayer de déterminer dans quelle mesure son ciblage par des agents pharmacologiques innovants a un impact sur le pronostic oncologique. Pour cela, nous avons commencé par démontrer que IRE1, une protéine senseur de l’UPR, a um impact sur l’agressivité tumorale, notamment par son activité d’épissage de l’ARNm codant pour XBP1. La signalisation induite par xpb1 entraine une infiltration macrophagique, une néo- angiogénèse et um profil invadif des GBM. Ensuite, nous proposons de definir une drogue ciblant l’axe IRE1/xpb1, la drogue candidate retenue étant le MKC8866, un inhibiteur sélectif de l’activité RNase d’IRE1. Enfin, nous proposons d’évaluer l’impact de cet inhibiteur sur le développement tumoral, par le biais d’un ciblage intracérébral, couplé à une exérese et une radio-chimiothérapie, dans un modele syngénique murin innovant. Ce ciblage nous a permis de mettre en évidence un bénéfice oncologique à cibler IRE1 en plus des thérapeutiques conventionnelles. Ce travail constitue une preuve de concept préclinique de l’efficacité du ciblage de l’UPR, et propose um modele préclinique de l’efficacité du ciblage de l’UPR, et propose um modele préclinique innovant pouvant servir à l’étude d’autres voies de signalisation d’intérêt.
- Open Access
- 12 November 2021
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 25 (23) , 10846-10856
Integration of Raman spectra with transcriptome data in glioblastoma multiforme defines tumour subtypes and predicts patient outcome
Raman spectroscopy is an imaging technique that has been applied to assess molecular compositions of living cells to characterize cell types and states. However, owing to the diverse molecular species in cells and challenges of assigning peaks to specific molecules, it has not been clear how to interpret cellular Raman spectra. Here, we provide firm evidence that cellular Raman spectra (RS) and transcriptomic profiles of glioblastoma can be computationally connected and thus interpreted. We find that the dimensions of high‐dimensional RS and transcriptomes can be reduced and connected linearly through a shared low‐dimensional subspace. Accordingly, we were able to predict global gene expression profiles by applying the calculated transformation matrix to Raman spectra and vice versa. From these analyses, we extract a minimal gene expression signature associated with specific RS profiles and predictive of disease outcome.
- 12 November 2021
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 25 (23) , 10846-10856
Open AccessIntegration of Raman spectra with transcriptome data in glioblastoma multiforme defines tumour subtypes and predicts patient outcome
Raman spectroscopy is an imaging technique that has been applied to assess molecular compositions of living cells to characterize cell types and states. However, owing to the diverse molecular species in cells and challenges of assigning peaks to specific molecules, it has not been clear how to interpret cellular Raman spectra. Here, we provide firm evidence that cellular Raman spectra (RS) and transcriptomic profiles of glioblastoma can be computationally connected and thus interpreted. We find that the dimensions of high‐dimensional RS and transcriptomes can be reduced and connected linearly through a shared low‐dimensional subspace. Accordingly, we were able to predict global gene expression profiles by applying the calculated transformation matrix to Raman spectra and vice versa. From these analyses, we extract a minimal gene expression signature associated with specific RS profiles and predictive of disease outcome.
- Open Access
- 1 February 2021
- Published by Elsevier in Annales de Chirurgie Plastique Esthétique
- Vol. 66 (1) , 76-79
Use of a skin perforator flap pedicled by the intercostal muscle for reconstruction of a posterior cervical defect
- 1 February 2021
- Published by Elsevier in Annales de Chirurgie Plastique Esthétique
- Vol. 66 (1) , 76-79
Open AccessUse of a skin perforator flap pedicled by the intercostal muscle for reconstruction of a posterior cervical defect
- 1 December 2020
- Published by Elsevier in Cancer Letters
- Vol. 494, 73-83
Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivo
- 1 December 2020
- Published by Elsevier in Cancer Letters
- Vol. 494, 73-83
Local intracerebral inhibition of IRE1 by MKC8866 sensitizes glioblastoma to irradiation/chemotherapy in vivo
- Open Access
Advanced computational and statistical multiparametric analysis of Susceptibility-Weighted Imaging to characterize gliomas and brain metastases
Susceptibility-weighted imaging (SWI) is a technique useful for evaluation of the internal structures of brain tumors, including microvasculature and microbleeds. Intratumoral patterns of magnetic susceptibility can be quantified by means of fractal analysis. Here, we propose a radiomics methodological pipeline to merge advanced fractal-based computational modelling with statistical analysis to objectively characterize the fingerprint of gliomas and brain metastases. Forty-seven patients with glioma (grades II-IV, according to the WHO 2016 classification system) and fourteen with brain metastases underwent 3 Tesla MRI using a SWI protocol. All images underwent computational analysis aimed to quantify three Euclidean parameters (related to tumor and SWI volume) and five fractal-based parameters (related to the pixel distribution and geometrical complexity of the SWI patterns). Principal components analysis, linear and quadratic discriminant analysis, K-nearest neighbor and support vector machine methods were used to discriminate between tumor types. The combination of parameters offered an objective evaluation of the SWI pattern in gliomas and brain metastases. The model accurately predicted 88% of glioblastoma, according to the quantification of intratumoral SWI features, failing to discriminate the other types. SWI is not normally used to classify brain tumors, however fractal-based multi-parametric computational analysis can be used to characterize intratumoral SWI patterns to objectively quantify tumors-related features. Specific parameters still have to be identified to provide completely automatic computerized differential diagnosis.
Open AccessAdvanced computational and statistical multiparametric analysis of Susceptibility-Weighted Imaging to characterize gliomas and brain metastases
Susceptibility-weighted imaging (SWI) is a technique useful for evaluation of the internal structures of brain tumors, including microvasculature and microbleeds. Intratumoral patterns of magnetic susceptibility can be quantified by means of fractal analysis. Here, we propose a radiomics methodological pipeline to merge advanced fractal-based computational modelling with statistical analysis to objectively characterize the fingerprint of gliomas and brain metastases. Forty-seven patients with glioma (grades II-IV, according to the WHO 2016 classification system) and fourteen with brain metastases underwent 3 Tesla MRI using a SWI protocol. All images underwent computational analysis aimed to quantify three Euclidean parameters (related to tumor and SWI volume) and five fractal-based parameters (related to the pixel distribution and geometrical complexity of the SWI patterns). Principal components analysis, linear and quadratic discriminant analysis, K-nearest neighbor and support vector machine methods were used to discriminate between tumor types. The combination of parameters offered an objective evaluation of the SWI pattern in gliomas and brain metastases. The model accurately predicted 88% of glioblastoma, according to the quantification of intratumoral SWI features, failing to discriminate the other types. SWI is not normally used to classify brain tumors, however fractal-based multi-parametric computational analysis can be used to characterize intratumoral SWI patterns to objectively quantify tumors-related features. Specific parameters still have to be identified to provide completely automatic computerized differential diagnosis.
- Open Access
- 22 April 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (4) , e0232141
Optimization of time frame binning for FDOPA uptake quantification in glioma
3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine (FDOPA) uptake quantification in glioma assessment can be distorted using a non-optimal time frame binning of time-activity curves (TAC). Under-sampling or over-sampling dynamic PET images induces significant variations on kinetic parameters quantification. We aimed to optimize temporal time frame binning for dynamic FDOPA PET imaging. Fourteen patients with 33 tumoral TAC with biopsy-proven gliomas were analysed. The mean SUVmax tumor-to-brain ratio (TBRmax) were compared at 20 min and 35 min post-injection (p.i). Five different time frame samplings within 20 min were compared: 11x10sec-6x15sec-5x20sec-3x300sec; 8x15sec– 2x30sec– 2x60sec– 3x300sec; 6x20sec– 8x60sec– 2x300sec; 10x30sec– 3x300sec and 4x45sec– 3x90sec– 5x150sec. The reversible single-tissue compartment model with blood volume parameter (VB) was selected using the Akaike information criterion. K1 values extracted from 1024 noisy simulated TAC using Monte Carlo method from the 5 different time samplings were compared to a target K1 value as the objective, which is the average of the K1 values extracted from the 33 lesions using an imaging-derived input function for each patient. The mean TBRmax was significantly higher at 20 min p.i. than at 35 min p.i (respectively 1.4 +/- 0.8 and 1.2 +/- 0.6; p <0.001). The target K1 value was 0.161 mL/ccm/min. The 8x15sec– 2x30sec– 2x60sec– 3x300sec time sampling was the optimal time frame binning. K1 values extracted using this optimal time frame binning were significantly different with K1 values extracted from the other time frame samplings, except with K1 values obtained using the 11x10sec– 6x15sec –5x20sec-3x300sec time frame binning. This optimal sampling schedule design (8x15sec– 2x30sec– 2x60sec– 3x300sec) could be used to minimize bias in quantification of FDOPA uptake in glioma using kinetic analysis.
- 22 April 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (4) , e0232141
Open AccessOptimization of time frame binning for FDOPA uptake quantification in glioma
3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine (FDOPA) uptake quantification in glioma assessment can be distorted using a non-optimal time frame binning of time-activity curves (TAC). Under-sampling or over-sampling dynamic PET images induces significant variations on kinetic parameters quantification. We aimed to optimize temporal time frame binning for dynamic FDOPA PET imaging. Fourteen patients with 33 tumoral TAC with biopsy-proven gliomas were analysed. The mean SUVmax tumor-to-brain ratio (TBRmax) were compared at 20 min and 35 min post-injection (p.i). Five different time frame samplings within 20 min were compared: 11x10sec-6x15sec-5x20sec-3x300sec; 8x15sec– 2x30sec– 2x60sec– 3x300sec; 6x20sec– 8x60sec– 2x300sec; 10x30sec– 3x300sec and 4x45sec– 3x90sec– 5x150sec. The reversible single-tissue compartment model with blood volume parameter (VB) was selected using the Akaike information criterion. K1 values extracted from 1024 noisy simulated TAC using Monte Carlo method from the 5 different time samplings were compared to a target K1 value as the objective, which is the average of the K1 values extracted from the 33 lesions using an imaging-derived input function for each patient. The mean TBRmax was significantly higher at 20 min p.i. than at 35 min p.i (respectively 1.4 +/- 0.8 and 1.2 +/- 0.6; p <0.001). The target K1 value was 0.161 mL/ccm/min. The 8x15sec– 2x30sec– 2x60sec– 3x300sec time sampling was the optimal time frame binning. K1 values extracted using this optimal time frame binning were significantly different with K1 values extracted from the other time frame samplings, except with K1 values obtained using the 11x10sec– 6x15sec –5x20sec-3x300sec time frame binning. This optimal sampling schedule design (8x15sec– 2x30sec– 2x60sec– 3x300sec) could be used to minimize bias in quantification of FDOPA uptake in glioma using kinetic analysis.
- Open Access
Reflux of Endoplasmic Reticulum proteins to the cytosol yields inactivation of tumor suppressors
In the past decades many studies reported Endoplasmic Reticulum (ER) resident proteins to localize to the cytosol but the mechanisms by which this occurs and whether these proteins exert cytosolic functions remain unknown. We found that select ER luminal proteins accumulate in the cytosol of glioblastoma cells isolated from mouse and human tumors. In cultured cells ER protein reflux to the cytosol occurs upon proteostasis perturbation. As such we investigated whether refluxed proteins gain new functions in the cytosol thus providing advantage to tumor cells. Using the ER luminal protein AGR2 as a model, we showed that it is refluxed to the cytosol where it binds and inhibits the tumor suppressor p53. We named this phenomenon ER to Cytosol Signaling (ERCYS) as an ER surveillance mechanism conserved in Eukaryotes to relieve the ER from its contents upon stress and to provide selective advantage to tumor cells through gain-of-cytosolic functions.
Open AccessReflux of Endoplasmic Reticulum proteins to the cytosol yields inactivation of tumor suppressors
In the past decades many studies reported Endoplasmic Reticulum (ER) resident proteins to localize to the cytosol but the mechanisms by which this occurs and whether these proteins exert cytosolic functions remain unknown. We found that select ER luminal proteins accumulate in the cytosol of glioblastoma cells isolated from mouse and human tumors. In cultured cells ER protein reflux to the cytosol occurs upon proteostasis perturbation. As such we investigated whether refluxed proteins gain new functions in the cytosol thus providing advantage to tumor cells. Using the ER luminal protein AGR2 as a model, we showed that it is refluxed to the cytosol where it binds and inhibits the tumor suppressor p53. We named this phenomenon ER to Cytosol Signaling (ERCYS) as an ER surveillance mechanism conserved in Eukaryotes to relieve the ER from its contents upon stress and to provide selective advantage to tumor cells through gain-of-cytosolic functions.
- 1 December 2019
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 70, 226-228
Fluorescein-guided surgery for spinal dural arteriovenous fistulas: A short series
- 1 December 2019
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 70, 226-228
Fluorescein-guided surgery for spinal dural arteriovenous fistulas: A short series
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, e943-e949
Spinal Dural Arteriovenous Fistulas: Clinical Outcome After Surgery Versus Embolization: A Retrospective Study
- 1 July 2019
- Published by Elsevier in World Neurosurgery
- Vol. 127, e943-e949
Spinal Dural Arteriovenous Fistulas: Clinical Outcome After Surgery Versus Embolization: A Retrospective Study
- Open Access
Novel IRE1-dependent proinflammatory signaling controls tumor infiltration by myeloid cells
Tumor cells are exposed to intrinsic and environmental challenges that trigger endoplasmic reticulum (ER) homeostasis alteration, in turn leading to ER stress. To cope with this, tumor cells engage an adaptive signaling pathway, the unfolded protein response (UPR) thus promoting the acquisition of malignant features. As such, glioblastoma multiforme (GBM), the most aggressive primary brain tumors, exhibit constitutive UPR signals to sustain growth. Herein, we showed that signaling elicited by one of the UPR sensors, IRE1, promotes GBM tumor invasion, angiogenesis and infiltration by macrophages. Hence, high IRE1 activity in tumors predicts worse outcome. We further dissect IRE1-dependent mechanisms that shape the brain tumor immune microenvironment towards myeloid cells. We identify an IRE1-dependent signaling pathway that directly controls the expression/release of proinflammatory chemokines (CXCL2, IL6, IL8) leading to tumor cell-mediated chemoattraction of neutrophils and macrophages. This pathway requires XBP1 non-conventional mRNA splicing and XBP1s-dependent expression of the E2 ubiquitin enzyme UBE2D3. The latter contributes to the degradation of the NFκB inhibitor IκB, leading to the up-regulation of proinflammatory chemokines. Our work identifies a novel IRE1/UBE2D3 proinflammatory signaling axis instrumental to pro-tumoral immune regulation of GBM.
Open AccessNovel IRE1-dependent proinflammatory signaling controls tumor infiltration by myeloid cells
Tumor cells are exposed to intrinsic and environmental challenges that trigger endoplasmic reticulum (ER) homeostasis alteration, in turn leading to ER stress. To cope with this, tumor cells engage an adaptive signaling pathway, the unfolded protein response (UPR) thus promoting the acquisition of malignant features. As such, glioblastoma multiforme (GBM), the most aggressive primary brain tumors, exhibit constitutive UPR signals to sustain growth. Herein, we showed that signaling elicited by one of the UPR sensors, IRE1, promotes GBM tumor invasion, angiogenesis and infiltration by macrophages. Hence, high IRE1 activity in tumors predicts worse outcome. We further dissect IRE1-dependent mechanisms that shape the brain tumor immune microenvironment towards myeloid cells. We identify an IRE1-dependent signaling pathway that directly controls the expression/release of proinflammatory chemokines (CXCL2, IL6, IL8) leading to tumor cell-mediated chemoattraction of neutrophils and macrophages. This pathway requires XBP1 non-conventional mRNA splicing and XBP1s-dependent expression of the E2 ubiquitin enzyme UBE2D3. The latter contributes to the degradation of the NFκB inhibitor IκB, leading to the up-regulation of proinflammatory chemokines. Our work identifies a novel IRE1/UBE2D3 proinflammatory signaling axis instrumental to pro-tumoral immune regulation of GBM.